To evaluate the contribution of endothelial Jagged1 to tumor angiogenesis, LLC cells were subcutaneously implanted in the dorsum of endothelial specific Jag1 gain- (eJag1OE) and loss-of-function mouse mutants (eJag1cKO). This evidence concerns the gene JAG1 and neoplasm.